Bulletin
Investor Alert

London Markets Close in:

Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

Market open

NVS
/zigman2/quotes/203243705/composite

$

84.31

Change

+0.17 +0.20%

Volume

Volume 470,689

Oct 22, 2020, 11:02 a.m.

Real time quotes

/zigman2/quotes/203243705/composite

Previous close

$ 84.14

$ 84.31

Change

+0.17 +0.20%

Day low

Day high

$84.04

$84.41

Open
Open: 84.21

52 week low

52 week high

$69.18

$99.84

Open

Market cap

$186.38B

Average volume

1.74M

P/E ratio

26.76

Rev. per Employee

$415,614

EPS

3.14

Dividend

3.09

Div yield

2.39%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. The Pandemic Speeds Up the Health-Care Revolution

    6:01 p.m. Oct. 6, 2020

    - Barron's Online

  2. Gilead reaches $21 billion deal for Immunomedics

    4:30 p.m. Sept. 13, 2020

    - MarketWatch.com

  3. Novartis Stock Should Rise 20%, Analyst Says

    11:28 a.m. Sept. 11, 2020

    - Barron's Online

  4. Stocks Close Mixed as Record Month Comes to a Close

    4:50 p.m. Aug. 31, 2020

    - Barron's Online

  5. Drug maker Teva’s U.S. unit indicted on price-fixing charges

    6:42 p.m. Aug. 25, 2020

    - Brent Kendall

  6. Novartis melanoma treatment disappoints in trial

    1:37 a.m. Aug. 24, 2020

    - MarketWatch.com

  7. Novartis MS drug Kesimpta gets FDA approval

    3:15 a.m. Aug. 21, 2020

    - MarketWatch.com

  8. These Companies Are Seeking a Cure for Sickle Cell

    11:53 a.m. July 25, 2020

    - Barron's Online

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. IPO Update: NLS Pharmaceutics Readies $20 Million IPO Plan

    5:34 p.m. Oct. 20, 2020

    - Seeking Alpha

  2. Bristol-Myers' Acquisition of Bluebird Seems to Make Sense

    5:17 p.m. Oct. 20, 2020

    - GuruFocus.com

  3. Foghorn Therapeutics Files Terms For $120 Million IPO

    2:25 p.m. Oct. 19, 2020

    - Seeking Alpha

  4. Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran

    9:55 a.m. Oct. 19, 2020

    - Zacks.com

  5. Top Research Reports for Novartis, Zoom Video & FIS

    1:31 p.m. Oct. 16, 2020

    - Zacks.com

  6. Pfizer, BioNTech Race to Meet Global Covid-19 Vaccine Needs

    4:03 p.m. Oct. 15, 2020

    - Bojan Pancevski

  7. Roche's (RHHBY) 9M20 Sales Affected by COVID-19 Outbreak

    10:18 a.m. Oct. 15, 2020

    - Zacks.com

  8. Gossamer Shares Pummeled on Asthma Study Results

    3:24 p.m. Oct. 13, 2020

    - GuruFocus.com

  9. Sizing Up Sangamo Therapeutics

    7:02 a.m. Oct. 13, 2020

    - Seeking Alpha

  10. Opthea Readies Plan For U.S. IPO

    6:38 p.m. Oct. 12, 2020

    - Seeking Alpha

  11. Sarepta: Leading The Genomic Medicine Pack

    10:43 a.m. Oct. 12, 2020

    - Seeking Alpha

  12. Pfizer's (PFE) Ibrance Fails in Early Breast Cancer Study

    10:26 a.m. Oct. 12, 2020

    - Zacks.com

  13. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.